Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
42868452	bm-bcr-qr	— (—)	38	144	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Liquid cancers, including Hilmo

41.16

21.92

4.8

1.0

—

Rare circulating lymphoid malignancy, including Hilmo

+∞

13.56

9.2

0.0

—

Malignant neoplasm

18.55

11.02

6.2

1.0

—

Malignant neoplasm

18.55

11.02

6.2

1.0

—

Malignant neoplasm, including Hilmo

18.44

10.99

6.2

1.0

—

Malignant neoplasm, wide definition

18.43

10.98

6.2

1.0

—

Acute lymphocytic leukaemia

+∞

10.48

10.2

0.0

—

Acute lymphocytic leukaemia, helper endpoint

+∞

10.48

10.2

0.0

—

Acute lymphocytic leukaemia, including Hilmo

+∞

10.48

10.2

0.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8.84

9.46

4.1

3.5

—

Chronic myeloid leukaemia, including Hilmo

+∞

9.41

1.0

0.0

—

Other bacterial diseases

8.98

8.65

6.3

1.4

—

Other bacterial diseases, including avohilmo

8.02

7.65

6.6

1.4

—

Any event in cancer register

10.38

7.62

7.2

1.0

—

Bacterial infection, other or unspecified

9.14

6.49

7.0

1.5

—

Bacterial infection, other or unspecified, including avohilmo

8.87

6.36

7.0

1.5

—

Fever of other and unknown origin

8.04

6.11

5.7

1.4

—

Neoplasms

10.49

5.69

8.5

1.0

—

ILD medications: immunosuppressive drugs

6.54

5.47

8.8

1.1

—

Other septicaemia

9.43

5.31

7.8

1.0

—

Chronic myeloid leukaemia

+∞

5.23

1.0

0.0

—

Other septicaemia, including avohilmo

8.53

5.05

7.8

1.0

—

Septicaemia

7.60

4.73

7.8

1.5

—

Erysipelas

6.46

3.89

3.3

1.5

—

Erysipelas, including avohilmo

5.70

3.83

4.3

1.5

—

Explicit Sepsis

5.06

3.66

7.8

1.3

—

Explicit Sepsis, including avohilmo

5.03

3.64

7.8

1.3

—

L04AX Other immunosuppressants

4.76

3.54

8.1

2.2

—

Second line medication for Crohn's disease

4.76

3.54

8.1

2.2

—

Metabolic disorders

3.90

3.45

2.7

4.1

—

L04AD Calcineurin inhibitors

10.01

2.98

14.8

1.0

—

Pain in limb

3.31

2.80

4.1

4.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3.29

2.78

8.1

1.9

—

Other and unspecified anaemias

5.05

2.72

1.1

3.3

—

Other anaemias

5.04

2.71

1.1

3.3

—

Coronary atherosclerosis

4.59

2.64

1.1

2.6

—

Influenza and pneumonia

2.96

2.58

2.6

4.5

—

Acute and subacute iridocyclitis

7.14

2.55

1.0

—

Anterior Iridocyclitis

7.14

2.55

1.0

—

Iridocyclitis

7.14

2.55

1.0

—

All influenza

5.45

2.54

1.5

6.7

—

Other and unspecified dermatitis

3.81

2.46

3.3

3.0

—

Pain, not elsewhere classified

6.25

2.37

1.2

1.0

—

Other specific joint derangements/joint disorders

3.50

2.33

2.8

4.9

—

Aplastic and other anaemias

4.00

2.27

1.1

2.9

—

Ischaemic heart disease, wide definition

3.79

2.27

1.0

2.4

—

First line medication for Crohn's disease

2.96

2.25

9.2

1.4

—

Conductive and sensorineural hearing loss

3.32

2.24

3.3

3.4

—

General symptoms and signs

3.13

2.19

4.9

1.7

—

N06DA Anticholinesterases

5.51

2.10

1.0

1.1

—

Use of anticholinesterases

5.51

2.10

1.0

1.1

—

Pain in joint

3.91

2.09

1.1

2.8

—

Implicit viral Sepsis, including avohilmo

4.99

2.06

1.2

1.0

—

Angina pectoris

4.42

2.06

1.0

1.7

—

COPD/asthma related infections

2.95

2.05

3.7

2.1

—

COPD/asthma/ILD related infections

2.95

2.05

3.7

2.1

—

Other soft tissue disorders, not elsewhere classified

2.72

2.03

4.4

4.0

—

Renal failure

3.51

2.01

1.1

3.2

—

Pain in throat and chest

2.96

1.96

4.4

4.2

—

Dermatitis

3.01

1.96

3.3

—

2.65

1.89

3.5

1.9

—

Disorders of sclera, cornea, iris and ciliary body

3.18

1.88

4.4

3.1

—

Solid cancers, including Hilmo

4.85

1.84

1.0

—

Headache

3.56

1.79

8.0

1.5

—

Other maternal disorders predominantly related to pregnancy

4.47

1.77

3.4

2.0

—

Viral infections characterized by skin and mucous membrane lesions

3.33

1.74

1.7

5.3

—

ILD medications

2.69

1.72

9.9

1.1

—

Malaise and fatigue

3.37

1.71

1.0

1.4

—

2.75

1.66

3.0

2.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.75

1.66

3.0

2.1

—

Myocardial infarction, strict

3.93

1.65

1.0

1.7

—

Implicit bacterial Sepsis

3.21

1.65

3.5

1.4

—

Myocardial infarction

3.88

1.63

1.0

1.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.74

1.61

3.3

1.8

—

Other disorders of veins

3.51

1.59

1.6

1.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.38

1.58

3.3

—

Certain infectious and parasitic diseases

2.92

1.55

9.1

1.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.63

1.53

8.6

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

3.12

1.51

6.7

6.9

—

Implicit bacterial Sepsis, including avohilmo

2.93

1.51

3.5

1.4

—

Bacterial Sepsis

2.92

1.50

3.5

1.4

—

Reimbursement for rheumatic diseases

2.84

1.49

1.2

3.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.54

1.45

1.0

3.6

—

Abnormal findings on diagnostic imaging of lung

3.16

1.44

1.0

1.5

—

Sensorineural hearing loss

2.59

1.44

1.0

3.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.50

1.43

5.7

2.8

—

COPD differential diagnosis

3.01

1.43

3.0

2.8

—

ILD differential diagnosis

3.01

1.43

3.0

2.8

—

Excluding asthma or asthma-COPD overlap

3.01

1.43

3.0

2.8

—

Other pulmonary diagnosis

3.01

1.43

3.0

2.8

—

Complications of surgical and medical care, not elsewhere classified

2.31

1.40

6.8

2.3

—

Acute sinusitis

3.03

1.38

5.2

2.0

—

Other inflammation of eyelid, including avohilmo

2.94

1.36

1.0

4.4

—

Other diseases of upper respiratory tract

2.26

1.32

1.1

4.4

—

Oral corticosteroids

2.20

1.32

2.9

3.8

—

Other functional intestinal disorders

2.84

1.30

1.0

5.9

—

Acute upper respiratory infections

2.16

1.30

4.1

1.8

—

Provisional assignment of new diseases of uncertain etiology

2.48

1.29

5.2

3.4

—

Codes for special purposes

2.48

1.29

5.2

3.4

—

Other diseases of pleura

2.71

1.23

1.0

1.4

—

Other disorders of ear

2.25

1.23

3.6

4.0

—

Primary gonarthrosis, bilateral

2.62

1.18

3.6

1.4

—

Persons encountering health services for examination and investigation

2.79

1.17

1.0

3.3

—

Genitourinary diseases

2.79

1.17

7.0

4.9

—

Asthma (mode)

2.63

1.11

1.2

2.8

—

Complications of medical and surgical care

2.25

1.09

3.3

2.4

—

Low back pain

2.25

1.09

2.4

2.6

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.25

1.09

3.1

1.9

—

Persons encountering health services for specific procedures and health care

2.12

1.09

1.1

5.2

—

Disorders of lipoprotein metabolism and other lipidaemias

2.24

1.08

1.0

2.7

—

Artrosis, including avohilmo

2.25

1.08

4.9

2.5

—

Depression or dysthymia

2.25

1.08

1.0

5.4

—

Emergency coronary revascularization (for ACS)

2.22

1.07

1.1

4.2

—

Diseases of the eye and adnexa

2.19

1.05

7.1

3.8

—

Bronchitis

2.00

1.05

3.4

2.2

—

Coxarthrosis, primary

2.30

1.03

1.0

1.4

—

Type 2 diabetes, wide definition

2.10

1.02

1.1

3.1

—

Inflammatory bowel disease treatment related agents

1.92

1.01

3.0

4.4

—

Ischaemic Stroke, excluding all haemorrhages

0.00

1.00

0.0

1.3

—

Glaucoma

2.23

0.99

2.2

1.1

—

Endocrine, nutritional and metabolic diseases

2.52

0.99

3.2

7.4

—

Transient ischemic attack

0.00

0.99

0.0

1.3

—

Cholelithiasis

1.99

0.97

3.3

1.5

—

Polyarthropathies

2.41

0.97

1.7

4.9

—

Finngen Rheumatological endpoints

1.99

0.96

3.1

4.4

—

Codeine

2.32

0.95

1.0

2.9

—

Hypothyroidism, strict autoimmune

2.19

0.92

4.2

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.94

0.90

1.4

3.0

—

Pure hypercholesterolaemia

2.12

0.89

1.0

2.8

—

Major coronary heart disease event

2.11

0.89

1.2

4.5

—

Implicit Sepsis

2.01

0.86

3.5

1.8

—

Lower back pain or/and sciatica

1.84

0.86

2.3

2.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.01

0.86

4.2

1.9

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.84

0.86

3.0

4.1

—

Gonarthrosis [arthrosis of knee](FG)

2.03

0.86

3.2

2.4

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.83

0.86

5.1

2.6

—

Pneumonias (Asthma/COPD co-morbidities)

1.80

0.84

3.0

3.9

—

Codeine or tramadol medication

1.81

0.84

1.0

3.3

—

Hard cardiovascular diseases

1.97

0.83

6.0

3.4

—

Implicit Sepsis, including avohilmo

1.95

0.83

3.5

1.8

—

Injury, poisoning and certain other consequences of external causes

0.00

0.83

0.0

2.9

—

Disorders of gallbladder, biliary tract and pancreas

1.78

0.83

3.0

3.5

—

Heart failure, not strict

1.92

0.82

1.5

3.9

—

Autoimmune diseases

1.76

0.82

2.6

4.5

—

All pneumoniae

1.73

0.81

3.0

4.0

—

Other disorders of skin and subcutaneous tissue

1.81

0.78

2.2

3.2

—

Dizziness and giddiness

1.79

0.77

1.2

2.7

—

Cardiovascular diseases

2.21

0.76

7.2

6.4

—

Tramadol

2.15

0.75

4.6

2.9

—

Disorders of eyelid, lacrimal system and orbit

1.90

0.75

2.7

3.6

—

Renal tubulo-interstitial diseases

1.90

0.75

1.3

4.0

—

Cholelithiasis, broad definition with cholecystitis

1.86

0.74

3.3

1.5

—

Any death

2.06

0.73

1.0

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

2.03

0.73

3.6

1.8

—

Intestinal infectious diseases

1.79

0.72

5.7

2.6

—

All chronic kidney diseases

1.99

0.72

2.2

2.3

—

Mycoses, including avohilmo

1.77

0.72

2.0

3.6

—

Dorsalgia

1.77

0.71

1.1

2.6

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.76

0.71

1.6

4.3

—

Care involving use of rehabilitation procedures

1.95

0.71

1.0

5.2

—

All kidney diseases

1.74

0.70

5.6

3.5

—

Percutaneous Coronary Intervention

1.90

0.69

1.2

4.8

—

Coronary revascularization (ANGIO or CABG)

1.90

0.69

1.2

4.8

—

Biguanides

1.69

0.68

1.0

3.1

—

Mood disorders, excluding more controls

1.64

0.66

1.1

4.4

—

Neurological diseases

1.79

0.64

7.2

5.2

—

Ischemic heart diseases

1.75

0.63

1.0

4.5

—

Injuries to the ankle and foot

1.71

0.62

2.4

4.7

—

Dermatitis and eczema

1.63

0.62

2.9

4.0

—

Cholecystectomy

1.70

0.62

1.6

1.8

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.59

0.61

5.1

2.6

—

Presence of cardiac and vascular implants and grafts

0.00

0.61

0.0

1.4

—

Triptan medication for migraine, min. 3 purchases

0.00

0.60

0.0

3.1

—

Fracture at wrist and hand level

0.00

0.60

0.0

4.5

—

Mouth breathing

0.00

0.60

0.0

5.4

—

Periapical abscess

0.00

0.59

0.0

4.1

—

Pneumonia, organism unspecified

1.71

0.58

1.3

4.6

—

Gonarthrosis,primary

1.64

0.56

3.2

1.8

—

Symptoms and signs involving the circulatory and respiratory systems

1.58

0.54

3.0

4.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.57

0.54

4.2

2.9

—

Mood [affective] disorders

1.60

0.50

1.1

2.9

—

Mood disorders

1.60

0.50

1.1

2.9

—

Other diseases of intestines

1.56

0.49

1.1

5.2

—

Abdominal and pelvic pain

1.53

0.49

7.1

3.3

—

Diseases of the ear and mastoid process

1.52

0.49

1.1

3.1

—

Soft tissue disorders

1.49

0.48

4.1

3.9

—

Diabetic retinopathy

0.00

0.42

0.0

1.7

—

Conduction disorders

0.00

0.41

0.0

1.5

—

Glucosamine medication

0.00

0.41

0.0

1.1

—

Fitting and adjustment of other devices

0.00

0.41

0.0

1.5

—

Pacemaker

0.00

0.41

0.0

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

0.00

0.41

0.0

3.0

—

Cardiodefibrillation

0.00

0.41

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.00

0.41

0.0

2.7

—

Other benign neoplasms of skin

0.00

0.41

0.0

1.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.50

0.41

4.0

1.8

—

Kela-code for severe mental illness

0.00

0.41

0.0

3.4

—

Spondylopathies

1.48

0.40

1.2

2.6

—

Symptoms and signs involving the skin and subcutaneous tissue

1.47

0.40

1.6

4.2

—

Unspecified mental disorder

0.00

0.40

0.0

3.2

—

Other disorders of urethra and urinary system

1.45

0.40

3.8

3.1

—

Other joint disorders

1.45

0.39

3.6

5.6

—

Autoimmune diseases related-to ILD

1.44

0.39

1.0

3.9

—

Other intervertebral disc disorders

1.42

0.39

1.6

2.6

—

Type 2 diabetes, strict (exclude DM1)

1.52

0.37

1.2

3.0

—

Type 2 diabetes, definitions combined

1.52

0.37

1.2

3.0

—

Type 2 diabetes

1.51

0.37

1.2

3.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.51

0.37

1.2

3.0

—

Other dorsopathies, not elsewhere classified

1.48

0.37

3.2

2.6

—

Disorders of the thyroid gland

1.44

0.36

3.2

3.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.42

0.36

1.0

4.5

—

Autoimmune diseases excluding thyroid diseases

1.41

0.36

1.0

4.5

—

Benzodiazepine use

1.40

0.35

2.0

2.7

—

Diabetes, varying definitions

1.34

0.34

1.2

4.8

—

Diabetes mellitus

1.33

0.34

1.2

4.8

—

Other antidepressants

1.32

0.31

1.0

3.0

—

Injuries to the knee and lower leg

1.26

0.30

3.0

4.1

—

Arthropathies

1.40

0.24

1.2

5.6

—

Depression

1.34

0.23

1.2

2.9

—

Injuries to the shoulder and upper arm

1.33

0.23

3.6

3.2

—

Hypothyroidism, other/unspecified

1.31

0.23

3.6

3.2

—

Paracetamol or NSAID medication

0.00

0.22

0.0

9.5

—

Single spontaneous delivery

0.00

0.22

0.0

1.3

—

Cystitis

1.24

0.22

1.2

3.1

—

Dyspnoea

1.24

0.22

4.6

3.2

—

Artificial joint operation, meniscal resection

1.23

0.22

3.6

2.2

—

Other (not insulin) diabetes medications

1.22

0.22

1.0

2.9

—

Labour and delivery complicated by fetal stress [distress]

0.00

0.22

0.0

2.4

—

Caries of enamel

1.21

0.22

7.0

2.5

—

Used for control exclusion in common control thyroid runs

1.20

0.22

3.4

4.9

—

Propionic acid derivatives

0.00

0.22

0.0

8.3

—

Anti-inflammatory and antirheumatic products, non-steroids

0.00

0.22

0.0

8.3

—

Acne, including avohilmo

0.00

0.21

0.0

4.0

—

Hypertensive Heart Disease

0.00

0.21

0.0

1.7

—

AV-block

0.00

0.21

0.0

1.0

—

Impacted teeth

0.00

0.21

0.0

6.0

—

Hypertensive heart and/or renal disease

0.00

0.21

0.0

1.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.19

0.21

1.0

4.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.21

0.0

6.7

—

Redundant prepuce, phimosis and paraphimosis

0.00

0.21

0.0

6.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

0.00

0.21

0.0

3.9

—

Strabismus

0.00

0.21

0.0

5.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

3.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

0.00

0.21

0.0

3.7

—

Cervicobrachial syndrome

0.00

0.21

0.0

2.1

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.21

0.0

6.1

—

Impingement syndrome of shoulder

0.00

0.21

0.0

1.0

—

IBD patients in KELA-register

0.00

0.21

0.0

6.6

—

Ventral hernia

0.00

0.21

0.0

2.2

—

Specific personality disorders

0.00

0.21

0.0

3.7

—

Thyrotoxicosis

0.00

0.21

0.0

2.2

—

Myalgia

0.00

0.21

0.0

2.2

—

Other strabismus

0.00

0.21

0.0

6.7

—

Acute alcohol intoxication

0.00

0.21

0.0

2.3

—

Cutaneous abscess, furuncle and carbuncle

0.00

0.21

0.0

3.4

—

Irritable bowel syndrome

0.00

0.21

0.0

2.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

0.00

0.21

0.0

3.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

0.00

0.21

0.0

2.2

—

Embedded and impacted teeth

0.00

0.21

0.0

6.7

—

Abnormalities of heart beat

0.00

0.21

0.0

2.4

—

Symptoms and signs involving the digestive system and abdomen

1.31

0.21

8.0

3.3

—

Superficial injury of wrist and hand

0.00

0.21

0.0

5.8

—

Personality disorders

0.00

0.21

0.0

3.3

—

Psoriasis

0.00

0.21

0.0

3.2

—

Infections with a predominantly sexual mode of transmission

0.00

0.21

0.0

3.5

—

Contact with and exposure to communicable diseases

0.00

0.21

0.0

5.8

—

Viral and other specified intestinal infections, including avohilmo

0.00

0.21

0.0

4.6

—

Disorders of adult personality and behaviour

0.00

0.21

0.0

4.0

—

Abrasion of teeth

0.00

0.21

0.0

1.9

—

Superficial injury of head

0.00

0.21

0.0

4.5

—

Schizophrenia or delusion, excluding more controls

0.00

0.20

0.0

4.0

—

Atopic dermatitis, strict definition

0.00

0.20

0.0

7.0

—

Abnormal serum enzyme levels

0.00

0.20

0.0

1.5

—

Non-invasive ventilation

0.00

0.20

0.0

4.2

—

Nerve, nerve root and plexus disorders

1.24

0.20

1.5

2.8

—

Use of hypnotics and sedatives

1.22

0.20

1.0

4.0

—

Diseases of salivary glands

0.00

0.20

0.0

1.9

—

Schizophrenia or delusion

0.00

0.20

0.0

3.8

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.20

0.0

3.8

—

Deforming dorsopathies

0.00

0.20

0.0

4.1

—

Any mental disorder

1.20

0.20

1.2

4.4

—

Episodal and paroxysmal disorders

1.17

0.19

1.2

4.8

—

Asthma, including avohilmo

1.24

0.19

1.1

4.4

—

Chronic lower respiratory diseases

1.23

0.19

1.1

4.5

—

Persons encountering health services in other circumstances, wide

1.20

0.18

3.1

4.0

—

Diseases of the skin and subcutaneous tissue

1.14

0.10

4.0

3.8

—

Gingivitis and periodontal diseases

1.12

0.10

3.8

—

Constipation

1.13

0.10

2.2

4.0

—

Asthma/COPD (KELA code 203)

1.11

0.10

1.2

4.5

—

Chronic periodontitis, including avohilmo

1.10

0.10

1.0

2.8

—

Periodontitis

1.10

0.10

1.0

2.8

—

Diabetes medication

1.08

0.10

1.0

4.7

—

Diabetes, insulin treatment (Kela reimbursement)

1.06

0.09

1.0

4.5

—

Injuries to the head

1.15

0.09

3.2

4.0

—

Chronic apical periodontitis

1.12

0.09

3.0

2.4

—

Benign neoplasm of eye and adnexa

0.00

0.0

1.0

—

Gastric ulcer

0.00

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

0.0

3.4

—

Cardiomyopathy

0.00

0.0

1.0

—

Diabetic maculopathy, excluding more controls

0.00

0.0

1.0

—

Mucosal proctocolitis

0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

0.0

1.0

—

Fall on same level

0.86

0.00

1.2

4.4

—

0.00

0.0

3.2

—

Rosacea

0.00

0.0

1.0

—

Schizophrenia

0.00

0.0

3.3

—

Fracture of skull and facial bones

0.00

0.0

3.9

—

Nummular dermatitis

0.00

0.0

1.0

—

Problems related to lifestyle

0.00

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.0

4.3

—

Seborrhoeic dermatitis

0.00

0.0

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.2

—

Coronary artery bypass grafting

0.00

0.0

2.2

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

0.0

5.3

—

Other disorders of the genitourinary system

0.00

0.0

1.0

—

Acute alcohol intoxication, ICD10

0.00

0.0

2.6

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

1.0

—

Falls/tendency to fall

0.89

0.00

1.2

4.7

—

Mental retardation

0.00

0.0

11.2

—

Emotionally unstable personality disorder

0.00

0.0

3.0

—

D07AA Corticosteroids, weak (group I)

0.00

-0.00

0.0

7.0

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

14.0

—

Convulsions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

-0.00

0.0

1.0

—

5-aminosalicylic acid

0.00

-0.00

0.0

5.7

—

Peripheral arterial reconstruction

0.00

-0.00

0.0

1.2

—

Thyrotoxicosis with diffuse goitre

0.00

-0.00

0.0

1.0

—

Disturbance of activity and attention

0.00

-0.00

0.0

8.1

—

Premature rupture of membranes

0.00

-0.00

0.0

4.8

—

Bipolar affective disorders

0.00

-0.00

0.0

4.3

—

Generalized anxiety disorder

0.00

-0.00

0.0

4.7

—

Poor fetal growth

0.00

-0.00

0.0

2.9

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

-0.00

0.0

2.4

—

Congenital malformations of heart and great arteries

0.00

-0.00

0.0

9.5

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Other disorders of bone

0.00

-0.00

0.0

2.3

—

Other keratitis

0.00

-0.00

0.0

1.0

—

Disorders of muscles

0.00

-0.00

0.0

1.0

—

Plantar fascial fibromatosis

0.00

-0.00

0.0

1.0

—

Chondropathies

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

8.3

—

Personality disorders, excluding more controls

0.00

-0.00

0.0

5.2

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.1

—

Cervicalgia

0.00

-0.00

0.0

2.3

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.2

—

Other bursopathies

0.00

-0.00

0.0

1.0

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

3.0

—

Atrophic disorders of skin

0.00

-0.00

0.0

1.2

—

Cellulitis

0.00

-0.00

0.0

1.0

—

Alcohol abuse, main dg

0.00

-0.00

0.0

1.0

—

Hyperkinetic disorders

0.00

-0.00

0.0

9.7

—

Allergic contact dermatitis

0.00

-0.00

0.0

3.4

—

Acne

0.00

-0.00

0.0

1.0

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

0.00

-0.00

0.0

2.5

—

Adhesive capsulitis of shoulder

0.00

-0.00

0.0

1.1

—

Ganglion

0.00

-0.00

0.0

2.3

—

Corneal ulcer

0.00

-0.00

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

False labour

0.00

-0.00

0.0

4.2

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

0.00

-0.00

0.0

3.2

—

Hyperkinetic disorders, excluding more controls

0.00

-0.00

0.0

8.0

—

Alcohol abuse, main dg, excluding more controls

0.00

-0.00

0.0

3.3

—

Spondylolisthesis/Spondylolysis

0.00

-0.00

0.0

1.0

—

Diagnoses used for exclusion with ILD

0.00

-0.00

0.0

1.1

—

Degenerative macular diseases

0.00

-0.00

0.0

1.2

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.2

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

3.4

—

Hydronephrosis

0.00

-0.00

0.0

1.0

—

Other disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Unspecified lump in breast

0.00

-0.00

0.0

3.0

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.0

—

Paroxysmal tachycardia

0.00

-0.00

0.0

3.6

—

Pulmonary embolism

0.00

-0.00

0.0

1.1

—

Valvular operations

0.00

-0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

7.0

—

Psoriasis vulgaris

0.00

-0.00

0.0

1.0

—

Other and unspecified urticaria

0.00

-0.00

0.0

5.7

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

3.0

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

3.6

—

Scabies, including avohilmo

0.00

-0.00

0.0

2.7

—

Viral and other specified intestinal infections

0.00

-0.00

0.0

4.9

—

Migraine without aura

0.00

-0.00

0.0

5.8

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

9.5

—

Other disorders of conjunctiva

0.00

-0.00

0.0

1.0

—

Septal defects

0.00

-0.00

0.0

11.2

—

Pulmonary heart disease, diseases of pulmonary circulation

0.00

-0.00

0.0

1.1

—

Pre-eclampsia

0.00

-0.00

0.0

3.2

—

Maternal care for other known or suspected fetal problems

0.00

-0.00

0.0

4.2

—

Other CVD

0.00

-0.00

0.0

1.1

—

Diplopia

0.00

-0.00

0.0

1.0

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.0

—

Pre-eclampsia or poor fetal growth

0.00

-0.00

0.0

2.8

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

-0.00

0.0

2.5

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.1

—

Disorders of psychological development

0.00

-0.00

0.0

6.0

—

Pulmonary heart disease

0.00

-0.00

0.0

1.1

—

Suicide or other Intentional self-harm

0.00

-0.00

0.0

3.9

—

Pre-eclampsia or eclampsia

0.00

-0.00

0.0

3.2

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

2.9

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

5.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

-0.00

0.0

1.1

—

Methotrexate

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

0.00

-0.00

0.0

1.1

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.0

—

Dermatophytosis

0.00

-0.00

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

7.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.2

—

Other diseases of arteries and capillaries

0.00

-0.00

0.0

1.0

—

Other congenital malformations, including avohilmo

0.00

-0.00

0.0

7.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis, other and/or unspecified

0.00

-0.00

0.0

1.0

—

Status post-ami

0.00

-0.00

0.0

2.2

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

-0.00

0.0

11.2

—

Type 1 diabetes, strict definition, subgroup 1

0.00

-0.00

0.0

14.0

—

Atopic dermatitis, strict definition with reimbursement

0.00

-0.00

0.0

8.0

—

Malignant neoplasm of digestive organs

0.00

-0.00

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

-0.00

0.0

14.0

—

Anomalies of dental arch relationship, including avohilmo

0.00

-0.00

0.0

2.7

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

3.0

—

Visual field defects

0.00

-0.00

0.0

1.0

—

Trigger finger

0.00

-0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

-0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.1

—

Inflammatory disease of uterus

0.00

-0.00

0.0

3.2

—

Graves disease, strict definition

0.00

-0.00

0.0

1.0

—

Somatoform disorder

0.00

-0.00

0.0

3.0

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.0

—

Hypotension

0.00

-0.00

0.0

1.2

—

Contact with machinery

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.00

-0.00

0.0

1.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

7.0

—

Special screening examination for infectious and parasitic diseases

0.00

-0.00

0.0

4.5

—

Speech therapy

0.00

-0.00

0.0

1.1

—

Pedal cyclist injured in transport accident

0.00

-0.00

0.0

2.6

—

Exposure to unspecified factor

1.03

-0.00

5.0

3.6

—

Other fall from one level to another

0.00

-0.00

0.0

4.3

—

Assault by bodily force

0.00

-0.00

0.0

3.8

—

Unspecified privation

0.00

-0.00

0.0

1.0

—

Open wound of ankle and foot

0.00

-0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

-0.00

0.0

3.4

—

Other diseases of urinary system

1.00

-0.00

3.6

3.3

—

Open wound of lower leg

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

-0.00

0.0

2.5

—

Superficial injury of hip and thigh

0.00

-0.00

0.0

1.2

—

Retinal vascular disorders

0.00

-0.00

0.0

1.2

—

Conjunctivitis (acute, non atopic), including avohilmo

1.01

-0.00

3.4

3.0

—

Retinal vascular occlusion

0.00

-0.00

0.0

1.2

—

Childhood allergy (age < 16)

0.00

-0.00

0.0

12.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations, including avohilmo

0.00

-0.00

0.0

2.5

—

Explicit bacterial Sepsis, including avohilmo

0.00

-0.00

0.0

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.0

—

Acute appendicitis, with complications

0.00

-0.00

0.0

1.0

—

Migraine without aura and triptan purchases

0.00

-0.00

0.0

1.1

—

Migraine with aura and triptan purchases

0.00

-0.00

0.0

1.1

—

Focal epilepsy

0.00

-0.00

0.0

6.7

—

Focal epilepsy, strict definition

0.00

-0.00

0.0

5.3

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Infective dermatitis

0.00

-0.00

0.0

1.0

—

Abnormal involuntary movements

0.00

-0.00

0.0

1.0

—

Selective serotonin reuptake inhibitors

0.96

-0.00

1.0

3.0

—

Coxibs

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

-0.00

0.0

7.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

-0.00

0.0

1.0

—

Acetic acid derivatives and related substances

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA)

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS